MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0120569
_PRIVATE_LIMITED.webp)
STG Pharmagenerics Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹110.75 Cr
▲ 19% YoY
Net profit · FY 2025
₹1.83 Cr
Net margin 1.7%
EBITDA · FY 2025
₹2.85 Cr
EBITDA margin 2.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹12 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About STG Pharmagenerics Private Limited
Data last updated:
STG Pharmagenerics Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Everest Pharma Generics(China) Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017FTC291263. Its GSTIN is 27AAECE5314L2ZJ (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹50 Lakh. It is led by directors Rajesh Madanlal Gupta (Whole-Time Director) and Tarun Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 604B Sai Samarth Business Park Near Wasan Motors Deonar Govandi (E), Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2025, the company reported a revenue of ₹110.75 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.83 Cr (net margin 1.7%) and EBITDA of ₹2.85 Cr (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years.
As per MCA filings, the company has open charges of ₹12 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
STG Pharmagenerics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0120569). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pkpharma.com.
Company details
CIN U51909MH2017FTC291263
Registration Number 291263
Incorporation Date 15 February 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Everest Pharma Generics(China) Ltd
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0120569
Recognitions & Rankings of STG Pharmagenerics
Contact details
STG Pharmagenerics Private Limited's registered office is in Mumbai, Maharashtra. Its website is pkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address604B Sai Samarth Business Park Near Wasan Motors Deonar Govandi (E), Mumbai, Maharashtra, India – 400088
- IndustryPharma, Drug Formulation & Development
To see the full contact details of STG Pharmagenerics Private Limited, buy the company report.
Comprehensive company report
STG Pharmagenerics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of STG Pharmagenerics is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of STG Pharmagenerics Private Limited, buy the company report.
Financials of STG Pharmagenerics Private Limited
FY 2025 filings availableSTG Pharmagenerics Private Limited reported revenue of ₹110.75 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹110.75 Cr ▲ 19%
Net profit · FY 2025
₹1.83 Cr margin 1.7%
EBITDA · FY 2025
₹2.85 Cr margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 63%
EBITDA CAGR growth
1 year
▲ 81%
3 years · compounded
▲ 205%
Revenue has grown at a compounded annual rate (CAGR) of 63% over three years, including 19% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.83 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of STG Pharmagenerics Private Limited, buy the company report.
Board of directors of STG Pharmagenerics Private Limited
STG Pharmagenerics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Madanlal Gupta | Whole-Time Director | 15 Feb 2017 | 9 Years 8 Months | Current |
| Tarun Gupta | Director | 15 Feb 2017 | 9 Years 8 Months | Current |
Auditor
STG Pharmagenerics Private Limited is audited by A. M. JAIN & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A. M. JAIN & Co. | FY 2023 | 103883W |
Shareholding
The shareholding of STG Pharmagenerics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of STG Pharmagenerics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2022 | 100633075 | Axis Bank Limited | ₹12 Cr | Open |
To see the full charge records of STG Pharmagenerics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
STG Pharmagenerics Private Limited has 2 court cases on record: 2 filed by STG Pharmagenerics. All cases are pending.
Total cases
2
Filed by the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Centurion Remedies Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary cases) | Filed by the company against Quickmed Pharma Solutions | Pending |
To see the full case history of STG Pharmagenerics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for STG Pharmagenerics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
STG Pharmagenerics has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE5314L2ZJ | Maharashtra | Active | 27 Nov 2021 |
| 02AAECE5314L1ZW | Himachal Pradesh | Active | 26 Aug 2022 |
To see the full GST registrations and return filing status of STG Pharmagenerics Private Limited, buy the company report.
Recent activity
STG Pharmagenerics Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Devindra Gupta ceased to be Additional Director on 30 Sep 2022.
AGM
Stg Pharmagenerics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stg Pharmagenerics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Axis Bank Limited of Rs. 12.00 Cr registered on 27 Jun 2022 with Charge ID 100633075 was modified on 24 Mar 2025.
Ceased
Devindra Gupta ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 12.00 Cr with Charge ID 100633075 was registered on 27 Jun 2022.
Appointed
Rajesh Madanlal Gupta was appointed as Whole-Time Director.
Appointed
Tarun Gupta was appointed as Director.
Incorporation
15 Feb 2017
Stg Pharmagenerics Private Limited was registered on 15 Feb 2017 with Roc Mumbai & aged 9 years 8 months as per MCA records.
Frequently asked questions
STG Pharmagenerics is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 February 2017 (9+ years old) and is registered under CIN U51909MH2017FTC291263.
STG Pharmagenerics has 2 current directors:
- Rajesh Madanlal Gupta - Whole-Time Director
- Tarun Gupta - Director
The latest financial statements of STG Pharmagenerics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of STG Pharmagenerics is 27AAECE5314L2ZJ, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AAECE5314L1ZW (Himachal Pradesh).
The CIN (Corporate Identification Number) of STG Pharmagenerics is U51909MH2017FTC291263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
STG Pharmagenerics has 2 court cases on record: 2 filed by the company. 2 are pending.
STG Pharmagenerics was incorporated on 15 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Devindra Gupta ceased to be Additional Director on 30 Sep 2022. Rajesh Madanlal Gupta was appointed as Whole-Time Director on 15 Feb 2017. Tarun Gupta was appointed as Director on 15 Feb 2017.
Yes, STG Pharmagenerics is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0120569).
STG Pharmagenerics can be reached through the website pkpharma.com. Its registered office is in Mumbai, Maharashtra, India.